1 | national resource for network | | | | | | | 2 | 0.39% |
2 | apps they need and | | | | | | | 2 | 0.39% |
3 | resource for network biology | | | | | | | 2 | 0.39% |
4 | enable researchers to find | | | | | | | 2 | 0.39% |
5 | apps add to cytoscape | | | | | | | 2 | 0.39% |
6 | a gene interaction network | | | | | | | 2 | 0.39% |
7 | patients in a cancer | | | | | | | 1 | 0.20% |
8 | of patients in a | | | | | | | 1 | 0.20% |
9 | clustering of patients in | | | | | | | 1 | 0.20% |
10 | stratification clustering of patients | | | | | | | 1 | 0.20% |
11 | for stratification clustering of | | | | | | | 1 | 0.20% |
12 | method for stratification clustering | | | | | | | 1 | 0.20% |
13 | a method for stratification | | | | | | | 1 | 0.20% |
14 | of tumor mutations nbs | | | | | | | 1 | 0.20% |
15 | tumor mutations nbs is | | | | | | | 1 | 0.20% |
16 | stratification of tumor mutations | | | | | | | 1 | 0.20% |
17 | networkbased stratification of tumor | | | | | | | 1 | 0.20% |
18 | image networkbased stratification of | | | | | | | 1 | 0.20% |
19 | structures image networkbased stratification | | | | | | | 1 | 0.20% |
20 | also uncovers many new | | | | | | | 1 | 0.20% |
21 | and also uncovers many | | | | | | | 1 | 0.20% |
22 | database and also uncovers | | | | | | | 1 | 0.20% |
23 | go database and also | | | | | | | 1 | 0.20% |
24 | the go database and | | | | | | | 1 | 0.20% |
25 | in the go database | | | | | | | 1 | 0.20% |
26 | machinery in the go | | | | | | | 1 | 0.20% |
27 | in a cancer cohort | | | | | | | 1 | 0.20% |
28 | on somatic mutations and | | | | | | | 1 | 0.20% |
29 | based on somatic mutations | | | | | | | 1 | 0.20% |
30 | profiles for each patient | | | | | | | 1 | 0.20% |
31 | factorization based clustering approach | | | | | | | 1 | 0.20% |
32 | matrix factorization based clustering | | | | | | | 1 | 0.20% |
33 | nonnegative matrix factorization based | | | | | | | 1 | 0.20% |
34 | interaction network and a | | | | | | | 1 | 0.20% |
35 | gene interaction network and | | | | | | | 1 | 0.20% |
36 | over a gene interaction | | | | | | | 1 | 0.20% |
37 | patient over a gene | | | | | | | 1 | 0.20% |
38 | each patient over a | | | | | | | 1 | 0.20% |
39 | for each patient over | | | | | | | 1 | 0.20% |
40 | genome wide somatic mutation | | | | | | | 1 | 0.20% |